Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

LSTA holding history

Lisata Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LSTA overviewAll 13F holders of LSTAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of LSTA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,909−100.0%Sold outHolders
Q1 20261,909$9.56K<0.1%+1,038+119.2%AddedHolders
Q4 2025871$1.62K<0.1%+871NewHolders
Q3 20250$00.0%−7,069−100.0%Sold outHolders
Q2 20257,069$20.5K<0.1%+7,068+706,800.0%AddedHolders
Q1 20251$2<0.1%00.0%UnchangedHolders
Q4 20241$3<0.1%−124−99.2%ReducedHolders
Q3 2024125$375<0.1%−3,584−96.6%ReducedHolders
Q2 20243,709$12.9K<0.1%+3,708+370,800.0%AddedHolders
Q1 20241$3<0.1%−235−99.6%ReducedHolders
Q4 2023236$645<0.1%+93+65.0%AddedHolders
Q3 2023143$306<0.1%+142+14,200.0%AddedHolders
Q2 20231$4<0.1%00.0%UnchangedHolders
Q1 20231$3<0.1%−5,896−100.0%ReducedHolders
Q4 20225,897$14.9K<0.1%+1,209+25.8%AddedHolders
Q3 20224,688$22.0K<0.1%+2,790+147.0%AddedConverted for a 1-for-15 splitHolders
Q2 202228,467$15.0K<0.1%+24,619+639.8%AddedHolders
Q1 20223,848$3.00K<0.1%−54,189−93.4%ReducedHolders
Q4 202158,037$49.0K<0.1%+46,444+400.6%AddedHolders
Q3 202111,593$14.0K<0.1%+11,583+115,830.0%AddedHolders
Q2 202110$00.0%00.0%UnchangedHolders
Q1 202110$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.